These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 39025928)

  • 1. A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing.
    Saulnier O; Zagozewski J; Liang L; Hendrikse LD; Layug P; Gordon V; Aldinger KA; Haldipur P; Borlase S; Coudière-Morrison L; Cai T; Martell E; Gonzales NM; Palidwor G; Porter CJ; Richard S; Sharif T; Millen KJ; Doble BW; Taylor MD; Werbowetski-Ogilvie TE
    Nat Cell Biol; 2024 Aug; 26(8):1233-1246. PubMed ID: 39025928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma.
    Stromecki M; Tatari N; Morrison LC; Kaur R; Zagozewski J; Palidwor G; Ramaswamy V; Skowron P; Wölfl M; Milde T; Del Bigio MR; Taylor MD; Werbowetski-Ogilvie TE
    Mol Oncol; 2018 Apr; 12(4):495-513. PubMed ID: 29377567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin accessibility mapping identifies mediators of basal transcription and retinoid-induced repression of OTX2 in medulloblastoma.
    Wortham M; Guo C; Zhang M; Song L; Lee BK; Iyer VR; Furey TS; Crawford GE; Yan H; He Y
    PLoS One; 2014; 9(9):e107156. PubMed ID: 25198066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate.
    Zagozewski J; Shahriary GM; Morrison LC; Saulnier O; Stromecki M; Fresnoza A; Palidwor G; Porter CJ; Forget A; Ayrault O; Hawkins C; Chan JA; Vladoiu MC; Sundaresan L; Arsenio J; Taylor MD; Ramaswamy V; Werbowetski-Ogilvie TE
    Nat Commun; 2020 Jul; 11(1):3627. PubMed ID: 32686664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The
    Ampudia-Mesias E; Cameron CS; Yoo E; Kelly M; Anderson SM; Manning R; Abrahante Lloréns JE; Moertel CL; Yim H; Odde DJ; Saydam N; Saydam O
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines.
    Bunt J; de Haas TG; Hasselt NE; Zwijnenburg DA; Koster J; Versteeg R; Kool M
    Mol Cancer Res; 2010 Oct; 8(10):1344-57. PubMed ID: 21047732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling medulloblastoma in vivo and with human cerebellar organoids.
    Ballabio C; Anderle M; Gianesello M; Lago C; Miele E; Cardano M; Aiello G; Piazza S; Caron D; Gianno F; Ciolfi A; Pedace L; Mastronuzzi A; Tartaglia M; Locatelli F; Ferretti E; Giangaspero F; Tiberi L
    Nat Commun; 2020 Jan; 11(1):583. PubMed ID: 31996670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OTX2 exhibits cell-context-dependent effects on cellular and molecular properties of human embryonic neural precursors and medulloblastoma cells.
    Kaur R; Aiken C; Morrison LC; Rao R; Del Bigio MR; Rampalli S; Werbowetski-Ogilvie T
    Dis Model Mech; 2015 Oct; 8(10):1295-309. PubMed ID: 26398939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma.
    Boulay G; Awad ME; Riggi N; Archer TC; Iyer S; Boonseng WE; Rossetti NE; Naigles B; Rengarajan S; Volorio A; Kim JC; Mesirov JP; Tamayo P; Pomeroy SL; Aryee MJ; Rivera MN
    Cancer Discov; 2017 Mar; 7(3):288-301. PubMed ID: 28213356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas.
    Adamson DC; Shi Q; Wortham M; Northcott PA; Di C; Duncan CG; Li J; McLendon RE; Bigner DD; Taylor MD; Yan H
    Cancer Res; 2010 Jan; 70(1):181-91. PubMed ID: 20028867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma.
    Qin N; Paisana E; Picard D; Leprivier G; Langini M; Custódia C; Cascão R; Conrad C; Peitzsch M; Stefanski A; Stühler K; Fischer U; Faria CC; Dietrich S; Reifenberger G; Remke M
    J Neurooncol; 2023 Nov; 165(2):329-342. PubMed ID: 37976029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells.
    Bunt J; Hasselt NE; Zwijnenburg DA; Hamdi M; Koster J; Versteeg R; Kool M
    Int J Cancer; 2012 Jul; 131(2):E21-32. PubMed ID: 21964830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma.
    Bunt J; Hasselt NE; Zwijnenburg DA; Koster J; Versteeg R; Kool M
    PLoS One; 2011; 6(10):e26058. PubMed ID: 22016811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OTX2 represses myogenic and neuronal differentiation in medulloblastoma cells.
    Bai RY; Staedtke V; Lidov HG; Eberhart CG; Riggins GJ
    Cancer Res; 2012 Nov; 72(22):5988-6001. PubMed ID: 22986744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant Otx2 expression enhances migration and induces ectopic proliferation of hindbrain neuronal progenitor cells.
    Wortham M; Jin G; Sun JL; Bigner DD; He Y; Yan H
    PLoS One; 2012; 7(4):e36211. PubMed ID: 22558385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition.
    Ferrucci V; de Antonellis P; Pennino FP; Asadzadeh F; Virgilio A; Montanaro D; Galeone A; Boffa I; Pisano I; Scognamiglio I; Navas L; Diana D; Pedone E; Gargiulo S; Gramanzini M; Brunetti A; Danielson L; Carotenuto M; Liguori L; Verrico A; Quaglietta L; Errico ME; Del Monaco V; D'Argenio V; Tirone F; Mastronuzzi A; Donofrio V; Giangaspero F; Picard D; Remke M; Garzia L; Daniels C; Delattre O; Swartling FJ; Weiss WA; Salvatore F; Fattorusso R; Chesler L; Taylor MD; Cinalli G; Zollo M
    Brain; 2018 May; 141(5):1300-1319. PubMed ID: 29490009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OTX1 and OTX2 Genes in Medulloblastoma.
    Figueira Muoio VM; Uno M; Oba-Shinjo S; da Silva R; Araújo Pereira BJ; Clara C; Matushita H; Marie SNK
    World Neurosurg; 2019 Jul; 127():e58-e64. PubMed ID: 30797919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14q22.3 duplication including OTX2 in a girl with medulloblastoma: A case report with literature review.
    Blake C; Widmeyer K; DAquila K; Mochizuki A; Smolarek TA; Pillay-Smiley N; Kim SY
    Am J Med Genet A; 2024 Jul; 194(7):e63604. PubMed ID: 38511879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.
    Bunt J; Hasselt NA; Zwijnenburg DA; Koster J; Versteeg R; Kool M
    Acta Neuropathol; 2013 Mar; 125(3):385-94. PubMed ID: 23179372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of human rhombic lip differentiation underlies medulloblastoma formation.
    Hendrikse LD; Haldipur P; Saulnier O; Millman J; Sjoboen AH; Erickson AW; Ong W; Gordon V; Coudière-Morrison L; Mercier AL; Shokouhian M; Suárez RA; Ly M; Borlase S; Scott DS; Vladoiu MC; Farooq H; Sirbu O; Nakashima T; Nambu S; Funakoshi Y; Bahcheli A; Diaz-Mejia JJ; Golser J; Bach K; Phuong-Bao T; Skowron P; Wang EY; Kumar SA; Balin P; Visvanathan A; Lee JJY; Ayoub R; Chen X; Chen X; Mungall KL; Luu B; Bérubé P; Wang YC; Pfister SM; Kim SK; Delattre O; Bourdeaut F; Doz F; Masliah-Planchon J; Grajkowska WA; Loukides J; Dirks P; Fèvre-Montange M; Jouvet A; French PJ; Kros JM; Zitterbart K; Bailey SD; Eberhart CG; Rao AAN; Giannini C; Olson JM; Garami M; Hauser P; Phillips JJ; Ra YS; de Torres C; Mora J; Li KKW; Ng HK; Poon WS; Pollack IF; López-Aguilar E; Gillespie GY; Van Meter TE; Shofuda T; Vibhakar R; Thompson RC; Cooper MK; Rubin JB; Kumabe T; Jung S; Lach B; Iolascon A; Ferrucci V; de Antonellis P; Zollo M; Cinalli G; Robinson S; Stearns DS; Van Meir EG; Porrati P; Finocchiaro G; Massimino M; Carlotti CG; Faria CC; Roussel MF; Boop F; Chan JA; Aldinger KA; Razavi F; Silvestri E; McLendon RE; Thompson EM; Ansari M; Garre ML; Chico F; Eguía P; Pérezpeña M; Morrissy AS; Cavalli FMG; Wu X; Daniels C; Rich JN; Jones SJM; Moore RA; Marra MA; Huang X; Reimand J; Sorensen PH; Wechsler-Reya RJ; Weiss WA; Pugh TJ; Garzia L; Kleinman CL; Stein LD; Jabado N; Malkin D; Ayrault O; Golden JA; Ellison DW; Doble B; Ramaswamy V; Werbowetski-Ogilvie TE; Suzuki H; Millen KJ; Taylor MD
    Nature; 2022 Sep; 609(7929):1021-1028. PubMed ID: 36131014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.